Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Aceglutamide aluminum [USAN:JAN]
RN: 12607-92-0
UNII: R7QTG0PMPX
InChIKey: IVVHAAOJLULJLK-YDXSIYMFSA-E

Classification Codes

  • Anti-Ulcerative
  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formula

  • C35-H59-Al3-N10-O24

Molecular Weight

  • 1084.8431
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Aceglutamide aluminum
  • Aceglutamide aluminum [USAN:JAN]

Synonyms

  • Aceglutamide aluminium
  • Aceglutamide aluminum
  • Aluminum aceglutamide
  • Glumal
  • KW 110
  • KW-110
  • N-Acetyl-L-glutamine aluminum salt
  • Pentakis (N(sup 2)-acetyl-L-glutaminato)tetrahydroxytrialuminum
  • Pentakis(N(sup 2)-acetyl-L-glutaminato)tetrahydroxytrialuminum
  • UNII-R7QTG0PMPX

Systematic Names

  • Aluminum, pentakis(N(sup 2)-acetyl-L-glutaminato)tetrahydroxytri-
  • Pentakis(N(2)-acetyl-L-glutaminato)tetrahydroxytrialuminum

Registry Numbers

CAS Registry Number

  • 12607-92-0

FDA UNII

  • R7QTG0PMPX

System Generated Number

  • 0012607920

Structure Descriptors

InChI

1S/5C7H12N2O4.3Al.4H2O/c5*1-4(10)9-5(7(12)13)2-3-6(8)11;;;;;;;/h5*5H,2-3H2,1H3,(H2,8,11)(H,9,10)(H,12,13);;;;4*1H2/q;;;;;3*+3;;;;/p-9/t5*5-;;;;;;;/m00000......./s1

InChIKey

IVVHAAOJLULJLK-YDXSIYMFSA-E

Smiles

CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Al+3]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 5gm/kg (5000mg/kg)   United States Patent Document. Vol. #3787466,
mouse LD50 intravenous 460mg/kg (460mg/kg)   United States Patent Document. Vol. #3787466,
mouse LD50 oral 13100mg/kg (13100mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: DECREASED MOTILITY OR CONSTIPATION
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 68, Pg. 602, 1972.
mouse LD50 subcutaneous > 120mg/kg (120mg/kg)   United States Patent Document. Vol. #3787466,
rabbit LD50 oral > 12500mg/kg (12500mg/kg)   Drugs in Japan Vol. 6, Pg. 14, 1982.
rat LD50 intraperitoneal 4200mg/kg (4200mg/kg)   United States Patent Document. Vol. #3787466,
rat LD50 intravenous 400mg/kg (400mg/kg)   United States Patent Document. Vol. #3787466,
rat LD50 oral > 14500mg/kg (14500mg/kg)   Drugs in Japan Vol. 6, Pg. 14, 1982.
rat LD50 subcutaneous > 10500mg/kg (10500mg/kg)   United States Patent Document. Vol. #3787466,